Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.33 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4190841 | 1.00 | EPHX1 (0.41) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL24567416 | 1.00 | EPHX1 (0.41) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL9643577 | 0.98 | EPHX1 (0.38) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL28738544 | 0.92 | CYP1A2 (0.39) | EPHX1CYP1A2 | |
| SCHEMBL12437882 | 0.84 | CA1 (0.43) | — | |
| SCHEMBL30645254 | 0.84 | EPHX1 (0.32) | EPHX1ALDH1A1 | |
| SCHEMBL29385123 | 0.80 | EPHX1 (0.48) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL29559353 | 0.80 | EPHX1 (0.48) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL28380195 | 0.80 | EPHX1 (0.48) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 | |
| SCHEMBL28249807 | 0.80 | EPHX1 (0.48) | EPHX1ALDH1A1ALOX5CYP1A2S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101035833-B | Cyclohexene oxide compound with cyclohexyl or long-chain alkyl and application thereof | TOAGOSEI CO LTD | 2010-09-01 | — | — | CN | disclosed |
| US-7612123-B2 | Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof | TOAGOSEI CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-1798251-B1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR BRANCHED LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO LTD (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | TOAGOSEI CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| CN-101035833-A | Cyclohexene oxide compound with cyclohexyl or long-chain alkyl and application thereof | TOAGOSEI CO LTD (JP) | 2007-09-12 | — | — | CN | disclosed |
| EP-1798251-A1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | RAD51, HEATR1, DCXR | EPHX1 492/4885ALDH1A1 740/4885ALOX5 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.